BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

7:11 PM
 | 
Oct 21, 2008
 |  BC Extra  |  Company News

Myriad planning spinout

Myriad (NASDAQ:MYGN) said it will spin off its research and drug development businesses from its core molecular diagnostics business, creating two separate public companies. Myriad recently retained...

Read the full 112 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >